HOME › DRUGS › DEFERIPRONE
ACTIVE SUBSTANCE / INN

DEFERIPRONE

Brand name(s): Upkanz, DEFERIPRONE, FERRIPROX, Deferiprone Lipomed, Ferriprox
FDA LISTED
EMA LISTED
PRESCRIPTION
APPLICATION WITHDRAWN
DISCONTINUED
ANDA208800
beta-Thalassemia;Iron Overload
ACTIVE SUBSTANCE
Deferiprone
REGULATORS
FDA · EMA
SPONSORS / MAH
Chiesi Farmaceutici S.p.A., Apotex B.V., CHIESI
TOTAL APPLICATIONS
6
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
DEFERIPRONEANDA208800TAROPrescription
FERRIPROXNDA212269CHIESIPrescription
FERRIPROXNDA208030CHIESIDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
FerriproxChiesi Farmaceutici S.p.A.Authorised25/08/1999beta-Thalassemia;Iron Overload
Deferiprone LipomedLipomed GmbHAuthorised19/09/2018Iron Overload;beta-Thalassemia
UpkanzApotex B.V.Application withdrawnPantothenate Kinase-Associated Neurodegeneration

FULL INTELLIGENCE ON DEFERIPRONE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →